Marek Martynowicz is a Respiratory physician. OpenAlex indexes 6 publications with 374 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3260 Providence Dr Ste 523
Anchorage, AK 995084608
Telephone
907-222-1725Provider last certified this registry record 6 Jan 2022.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20254 payments
- GlaxoSmithKline, LLC.Program year20253 payments
- Amgen Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
59.3%Corticosteroid39.3%Trelegy Ellipta65%Breo Ellipta19%Breztri Aerosphere7%Dulera6%Fluticasone Propionate3%Part D<11 patientsbeta2-Adrenergic Agonist11%Albuterol Sulfate Hfa78%Ventolin Hfa22%Part D≥38 patients+ 2 more classes in this area
Anti-infectives
20.1%Macrolide Antimicrobial17.1%Azithromycin100%Part D≥76 patientsPenicillins with extended spectrum3%Amoxicillin-Clavulanate Potass100%Part D≥19 patientsMetabolism & gastrointestinal
16%Corticosteroid16%Prednisone100%Part D≥79 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Regional Expansion of Oleic Acid–Injured Lungs
American Journal of Respiratory and Critical Care Medicine
1999 - Mechanisms of Regional Lung Expansion in Acute Respiratory Distress Syndrome
Yearbook of intensive care and emergency medicine
1999
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”